Cited 103 times in
A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.